Anti-arthritic effects of immunomodulatory peptide injected in joints

Current Drug Delivery

Volumn 8, Issue 6, 2011, Pages 600-606

  Lu, Yun ^a,b   Sharma, Raghwa ^a   Ali, Marina ^a   Byth, Karen ^c   Manolios, Nicholas ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b Tiajing Orthopaedic Hospital   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

Adjuvant induced arthritis; Animal model; Inflammation; Intra articular injection; Peptides; Therapeutics

Indexed keywords

ANTIRHEUMATIC AGENT; CYCLOSPORIN; DEXAMETHASONE; IMMUNOMODULATING AGENT; PEPTIDE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FIBROSIS; FOREFOOT; HISTOPATHOLOGY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; X RAY;

ANIMALS; ANKLE JOINT; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; FEMALE; IMMUNOLOGIC FACTORS; INJECTIONS, INTRA-ARTICULAR; MYCOBACTERIUM TUBERCULOSIS; OLIGOPEPTIDES; RATS; RATS, WISTAR;

EID: 80054084851     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/156720111797635478     Document Type: Article

References (23)

1. Buch, M.; Emery, P. The aetiology and pathogenesis of rheumatoid arthritis. Hosp. Pharmacist, 2002, 9, 5-10.
2. Doran, M. F.; Pond, G. R.; Crowson, C. S.; O'Fallon, W. M.; Gabriel, S. E. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota over a forty-year period. Arthritis Rheum., 2002, 46, 625.
3. Lee, D. M.; Weinblatt, M. E. Rheumatoid arthritis. Lancet 2001, 358 (9285), 903-911.
4. Harris Jr, E. D.; Schur, P. H. Pathogenesis Of Rheumatoid Arthritis. In Up to date, Maini, R. N., Ed. UpToDate: Waltham, MA, 2009.
5. Ali, M.; Manolios, N. Peptide-based therapies for arthritis. Fut. Rheumatol., 2007, 2 (3), 287-296.
6. Latham, P. W. Therapeutic peptides revisited. Nat. Biotechnol., 1999, 17, 755-757.
7. Pohlers, D.; Schmidt-Weber, C. B.; Franch, A.; Kuhlmann, J.; Bräuer, R.; Emmrich, F.; Kinne, R. W. Differential clinical efficacy of anti-CD4 monoclonal antibodies in rat adjuvant arthritis is paralleled by differential influence on NF-κB binding activity and TNF-α secretion of T cells. Arthritis Res., 2002, 4, 184-189.
8. Manolios, N.; Bonifacino, J. S.; Klausner, R. D. Transmembrane helical interactions and the assembly of the T cell receptor complex. Science, 1990, 249, 274-277.
9. Wang, X. M.; Djordjevic, J. T.; Bender, V.; N., M. T cell antigen receptor (TCR) transmembrane peptides colocalise with TCR, not lipid rafts, in surface membranes. Cell. Immunol., 2002, 215, 12-19.
10. Manolios, N.; Collier, S.; Taylor, J.; Pollard, J.; Harrison, L.; Bender, V. T-cell antigen receptor transmembrane peptides modulate T-cell function and T-cell mediated disease. Nat. Med., 1997, 3 (1), 84-87.
11. Manolios, N.; Letourneur, F.; Bonifacino, J. S.; Klausner, R. D. Pairwise, cooperative and inhibitory interactions describe the assembly and probable structure of the T cell antigen receptor. EMBO J., 1991, 10 (7), 1643-1651.
12. Amon, M. A.; Ali, M.; Bender, V.; Chan, Y.-N.; Toth, I.; Manolios, N. Lipidation and Glycosylation of a T-cell Antigen Receptor (TCR) transmembrane hydrophobic peptide dramatically enhances in vitro and in vivo function. BBA-Mol Cell Res, 2006, 1763 (8), 879-888.
13. Dumont, F. J.; Staruch, M. J.; Koprak, S. L.; Melino, M. R.; Sigal, N. H. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J. Immunol., 1990, 144, 251-258.
14. Bierer, B. E.; Mattila, P. S.; Standaert, R. F.; Herzenberg, L. A.; Burakoff, S. J.; Crabtree, G.; Schreiber, S. L. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc. Natl. Acad. Sci. USA, 1990, 87, 9231-9235.
15. Lin, C. S.; Boltz, R. C.; Siekierka, J. J.; Sigal, N. H. FK506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes. Cell Immunol., 1991, 133, 269-284.
16. DeGrado, W. F.; Musso, G. F.; Lieber, M.; Kaiser, E. T.; Kezdy, F. J. Kinetics and mechanism of haemolysis induced by mellitins and by a synthetic mellitin analogue. Biophys. J., 1982, 37, 329-338.
17. Higashijima, T.; Uzu, S.; Nakajima, T.; Ross, E. M. Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins). J. Biol. Chem., 1988, 263, 6491-6494
18. Kurosaka, N.; Ali, M.; Byth, K.; Manolios, N. The mode of antiarthritic peptide delivery impacts on the severity and outcome of adjuvant induced arthritis. APLAR J. Rheumatol., 2007, 10, 198-203.
19. Mi, Z.; Mai, J.; Lu, X.; Robbins, P. D. Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo. Mol. Ther., 2000, 2 (4), 339-347.
20. Amon, M. A.; Ali, M.; Bender, V.; Hall, K.; Aguilar, M.-I.; Aldrich-Wright, J.; Manolios, N. Kinetic and conformational properties of a novel T-cell antigen receptor transmembrane peptide in model membranes. J. Pept. Sci., 2008, 14, 714-724.
21. Gollner, G. P.; Muller, G.; Alt, R.; Knop, J.; Enk, A. H. Therapeutic application of T cell receptor mimic peptides or cDNA in the treatment of T cell-mediated skin diseases. Gene Ther., 2000, 7, 1000-1004.
22. Collier, S.; Bolte, A.; Manolios, N. Discrepancy in CD3- transmembrane peptide activity between in vitro and in vivo T-cell inhibition. Scand. J. Immunol., 2006, 64 (4), 388-391.
23. Mahnke, K.; Qian, Y.; Knop, J.; Enk, A. H. Dendritic cells, engineered to secrete a T-cell receptor mimic peptide, induce antigen-specific immunosuppression in vivo. Nat. Biotechnol., 2003, 21, 903-908.